VolitionRX Ltd [AMEX: VNRX] slipped around -0.03 points on Tuesday, while shares priced at $0.3 at the close of the session, down -9.97%.
VolitionRX Ltd stock is now -63.14% down from its year-to-date (YTD) trading value. VNRX Stock saw the intraday high of $0.3543 and lowest of $0.295 per share. The company’s 52-week high price is 0.94, which means current price is +1.32% above from all time high which was touched on 06/23/25.
Compared to the average trading volume of 622.26K shares, VNRX reached a trading volume of 33280518 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about VolitionRX Ltd [VNRX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VNRX shares is $2.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VNRX stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for VolitionRX Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 08, 2025. The new note on the price target was released on February 01, 2023, representing the official price target for VolitionRX Ltd stock. Previously, the target price had yet another drop from $8 to $7, while Cantor Fitzgerald kept a Overweight rating on VNRX stock.
How has VNRX stock performed recently?
VolitionRX Ltd [VNRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.60. With this latest performance, VNRX shares dropped by -31.71% in over the last four-week period, additionally sinking by -39.21% over the last 6 months – not to mention a drop of -50.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VNRX stock in for the last two-week period is set at 27.76, with the RSI for the last a single of trading hit 0.0390, and the three-weeks RSI is set at 0.0411 for VolitionRX Ltd [VNRX]. The present Moving Average for the last 50 days of trading for this stock 0.4794, while it was recorded at 0.3228 for the last single week of trading, and 0.5704 for the last 200 days.
VolitionRX Ltd [VNRX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and VolitionRX Ltd [VNRX] shares currently have an operating margin of -1542.24% and a Gross Margin at 14.42%. VolitionRX Ltd’s Net Margin is presently recorded at -1554.31%.
VolitionRX Ltd (VNRX) Capital Structure & Debt Analysis
VolitionRX Ltd (VNRX) Efficiency & Liquidity Metrics
VolitionRX Ltd (VNRX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, VolitionRX Ltd. (VNRX) effectively leverages its workforce, generating an average of -$269176.47 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.12% and a Quick Ratio of 0.12%, indicating strong ability to cover short-term liabilities.
Insider trade positions for VolitionRX Ltd [VNRX]
There are presently around $21.27%, or 25.27%% of VNRX stock, in the hands of institutional investors. The top three institutional holders of VNRX stocks are: LAGODA INVESTMENT MANAGEMENT, L.P. with ownership of 5.44 million shares, which is approximately 6.578%. VANGUARD GROUP INC, holding 0.64 million shares of the stock with an approximate value of $$0.39 million in VNRX stocks shares; and VANGUARD GROUP INC, currently with $$0.38 million in VNRX stock with ownership which is approximately 0.7676%.
